Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Authors
Keywords
-
Journal
Scientific Reports
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-08
DOI
10.1038/s41598-023-37280-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in peptide-mediated cytosolic delivery of proteins
- (2021) Macarena Sánchez-Navarro ADVANCED DRUG DELIVERY REVIEWS
- Challenge to overcome current limitations of cell-penetrating peptides
- (2021) Gyu Chan Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide
- (2020) N.G. Eissa et al. BIOCHEMICAL JOURNAL
- Internalization mechanisms of cell-penetrating peptides
- (2020) Ivana Ruseska et al. Beilstein Journal of Nanotechnology
- Cell Penetrating Peptides, Novel Vectors for Gene Therapy
- (2020) Rebecca E. Taylor et al. Pharmaceutics
- The world of cell penetrating: the future of medical applications
- (2020) Annarita Falanga et al. Future Medicinal Chemistry
- Transferrin Receptor-Mediated Uptake at the Blood–Brain Barrier Is Not Impaired by Alzheimer’s Disease Neuropathology
- (2019) Philippe Bourassa et al. MOLECULAR PHARMACEUTICS
- Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
- (2019) Justine Habault et al. MOLECULES
- The role of molecular simulations in understanding the mechanisms of cell-penetrating peptides
- (2019) Lauren M. Reid et al. DRUG DISCOVERY TODAY
- Targeting the transferrin receptor for brain drug delivery
- (2019) Kasper Bendix Johnsen et al. PROGRESS IN NEUROBIOLOGY
- Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines
- (2019) Sanjay G. Patel et al. Scientific Reports
- Cell penetrating peptides: the potent multi-cargo intracellular carriers
- (2019) Kimia Kardani et al. Expert Opinion on Drug Delivery
- Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia
- (2019) Sateesh Krishnamurthy et al. Nature Communications
- Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
- (2018) Thomas Del’Guidice et al. PLoS One
- Cell penetrating peptides: A concise review with emphasis on biomedical applications
- (2018) Hossein Derakhshankhah et al. BIOMEDICINE & PHARMACOTHERAPY
- A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery
- (2018) Katrin Hoffmann et al. Scientific Reports
- Basic Considerations for the Use of Monoclonal Antibodies in Migraine
- (2018) Morris Levin et al. HEADACHE
- Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity
- (2017) Daniela Kalafatovic et al. MOLECULES
- Cell-Penetrating Peptides: From Basic Research to Clinics
- (2017) Giulia Guidotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
- (2017) Roland Böttger et al. PLoS One
- Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form
- (2016) Yuko Iwase et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
- (2015) Sofie Stalmans et al. PLoS One
- The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions
- (2014) Esther Steiner et al. CELL AND TISSUE RESEARCH
- Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics
- (2014) Arite Mickan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Insulin Reverses the High-Fat Diet-Induced Increase in Brain A and Improves Memory in an Animal Model of Alzheimer Disease
- (2014) M. Vandal et al. DIABETES
- Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice
- (2014) Wael Alata et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation
- (2014) P. J. Tacken et al. JOURNAL OF IMMUNOLOGY
- Mechanistic Insight into CM18-Tat11 Peptide Membrane-Perturbing Action by Whole-Cell Patch-Clamp Recording
- (2014) Anna Fasoli et al. MOLECULES
- Altered cerebral vascular volumes and solute transport at the blood–brain barriers of two transgenic mouse models of Alzheimer's disease
- (2014) Tuan Minh Do et al. NEUROPHARMACOLOGY
- Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
- (2013) Li-Li Zou et al. Current Neuropharmacology
- Brain Bioavailability of Human Intravenous Immunoglobulin and its Transport through the Murine Blood–Brain Barrier
- (2013) Isabelle St-Amour et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Influence of Short-Chain Cell-Penetrating Peptides on Transport of Doxorubicin Encapsulating Receptor-Targeted Liposomes Across Brain Endothelial Barrier
- (2013) Gitanjali Sharma et al. PHARMACEUTICAL RESEARCH
- In Vitro Efficient Transfection by CM18-Tat11 Hybrid Peptide: A New Tool for Gene-Delivery Applications
- (2013) Fabrizio Salomone et al. PLoS One
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape
- (2012) Fabrizio Salomone et al. JOURNAL OF CONTROLLED RELEASE
- Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues
- (2012) Yan Ma et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- The Pharmacokinetics of Cell-Penetrating Peptides
- (2010) Dikran Sarko et al. MOLECULAR PHARMACEUTICS
- Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
- (2010) Benjamin Bitler et al. Recent Patents on Anti-Cancer Drug Discovery
- In vivo biodistribution and efficacy of peptide mediated delivery
- (2010) Peter Järver et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cell penetrating peptides: overview and applications to the delivery of oligonucleotides
- (2009) F. Said Hassane et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study
- (2009) Melissa Ouellet et al. NEUROCHEMISTRY INTERNATIONAL
- Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
- (2009) Fanchon Bourasset et al. NEUROPHARMACOLOGY
- Detailed Analysis Concerning the Biodistribution and Metabolism of Human Calcitonin-Derived Cell-Penetrating Peptides
- (2008) I. Neundorf et al. BIOCONJUGATE CHEMISTRY
- Cell Penetrating Peptides for In Vivo Molecular Imaging Applications
- (2008) Veerle Kersemans et al. CURRENT PHARMACEUTICAL DESIGN
- Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
- (2008) Noriyasu Kamei et al. JOURNAL OF CONTROLLED RELEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More